PDC*line
Corteria Pharmaceuticals appoints Mark Pruzanski as Chairman of its Board of Directors
©Versanis
Bioxodes
Visibility and market recognition for a biopharma company
Axoltis Pharma presents promising results from phase 1b clinical trial of innovative drug candidate for neurodegenerative diseases
Naobios receives $1.87M (€1.7M) in support of vaccine development
© Naobios
PDC*line Pharma completes enrolment of four cohorts of patients in PDC-LUNG-101 phase I/II clinical trial
©PDCline
Orphelia Pharma secures US patent covering KIZFIZO®, first drinkable formulation of temozolomide
Jeremy Bastid
Clean Cells doubles capacity with opening of new production suites
© Clean Cells
Bioxodes closes €12 million in Series A funding round
Cell-Easy and Toulouse University Hospital obtain IMPD approval for first-in-human clinical trial in systemic sclerosis, using promising allogeneic approach
© Cell-Easy